Kurzrock R - Search Results

1

Successful treatment of Castleman's disease with interleukin-1 receptor antagonist (Anakinra).

El-Osta H, Janku F, Kurzrock R. El-Osta H, et al. Among authors: kurzrock r. Mol Cancer Ther. 2010 Jun;9(6):1485-8. doi: 10.1158/1535-7163.MCT-10-0156. Epub 2010 May 25. Mol Cancer Ther. 2010. PMID: 20501803 Free PMC article.

2

Interleukin-1 and its inhibitors: a biologic and therapeutic model for the role of growth regulatory factors in leukemias.

Kurzrock R, Wetzler M, Estrov Z, Talpaz M. Kurzrock R, et al. Cytokines Mol Ther. 1995 Sep;1(3):177-84. Cytokines Mol Ther. 1995. PMID: 9384674 Review.

3

Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis.

Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R. Ebrahimi B, et al. Among authors: kurzrock r. Cancer. 2004 Dec 15;101(12):2727-36. doi: 10.1002/cncr.20672. Cancer. 2004. PMID: 15526319 Free article.

4

Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha.

Braiteh F, Boxrud C, Esmaeli B, Kurzrock R. Braiteh F, et al. Among authors: kurzrock r. Blood. 2005 Nov 1;106(9):2992-4. doi: 10.1182/blood-2005-06-2238. Epub 2005 Jul 14. Blood. 2005. PMID: 16020507 Free article.

5

Novel in vivo imaging shows up-regulation of death receptors by paclitaxel and correlates with enhanced antitumor effects of receptor agonist antibodies.

Gong J, Yang D, Kohanim S, Humphreys R, Broemeling L, Kurzrock R. Gong J, et al. Among authors: kurzrock r. Mol Cancer Ther. 2006 Dec;5(12):2991-3000. doi: 10.1158/1535-7163.MCT-06-0188. Epub 2006 Dec 5. Mol Cancer Ther. 2006. PMID: 17148761

6

Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer.

Li L, Ahmed B, Mehta K, Kurzrock R. Li L, et al. Among authors: kurzrock r. Mol Cancer Ther. 2007 Apr;6(4):1276-82. doi: 10.1158/1535-7163.MCT-06-0556. Mol Cancer Ther. 2007. PMID: 17431105

7

Studies in target-based treatment.

Kurzrock R. Kurzrock R. Mol Cancer Ther. 2007 May;6(5):1477. doi: 10.1158/1535-7163.MCT-07-0255. Epub 2007 May 4. Mol Cancer Ther. 2007. PMID: 17483434

8

Cutaneous castleman's disease responds to anti interleukin-6 treatment.

Ahmed B, Tschen JA, Cohen PR, Zaki MH, Rady PL, Tyring SK, Corringham RE, Kurzrock R. Ahmed B, et al. Among authors: kurzrock r. Mol Cancer Ther. 2007 Sep;6(9):2386-90. doi: 10.1158/1535-7163.MCT-07-0256. Epub 2007 Aug 31. Mol Cancer Ther. 2007. PMID: 17766835

9

Studies in target-based treatment.

Kurzrock R. Kurzrock R. Mol Cancer Ther. 2007 Sep;6(9):2385. doi: 10.1158/1535-7163.MCT-06-9S. Epub 2007 Sep 10. Mol Cancer Ther. 2007. PMID: 17846118 No abstract available.

10

Interleukin-6 and its receptor in cancer: implications for translational therapeutics.

Hong DS, Angelo LS, Kurzrock R. Hong DS, et al. Among authors: kurzrock r. Cancer. 2007 Nov 1;110(9):1911-28. doi: 10.1002/cncr.22999. Cancer. 2007. PMID: 17849470 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,016 results

Search Page

Filters